Cheng‐mei Tian

841 total citations · 1 hit paper
24 papers, 534 citations indexed

About

Cheng‐mei Tian is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Cheng‐mei Tian has authored 24 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 9 papers in Genetics and 6 papers in Cancer Research. Recurrent topics in Cheng‐mei Tian's work include Extracellular vesicles in disease (7 papers), Inflammatory Bowel Disease (7 papers) and MicroRNA in disease regulation (6 papers). Cheng‐mei Tian is often cited by papers focused on Extracellular vesicles in disease (7 papers), Inflammatory Bowel Disease (7 papers) and MicroRNA in disease regulation (6 papers). Cheng‐mei Tian collaborates with scholars based in China. Cheng‐mei Tian's co-authors include Lisheng Wang, Defeng Li, Yujie Liang, Haoming Xu, Jun Yao, Min‐zheng Zhu, Meifeng Yang, Yuqiang Nie, Jing Xu and Yuan Zhang and has published in prestigious journals such as Frontiers in Microbiology, Frontiers in Pharmacology and International Journal of Nanomedicine.

In The Last Decade

Cheng‐mei Tian

20 papers receiving 530 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Edible exosome-like nanoparticles from portulaca oleracea L mitigate DSS-induced colitis via facilitating double-positive CD4+CD8+T cells expansion

2023 102 citations Min‐zheng Zhu, Haoming Xu et al. Journal of Nanobiotechnology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cheng‐mei Tian China	13	316	126	100	59	52	24	534
Min‐zheng Zhu China	13	300 0.9×	96 0.8×	93 0.9×	57 1.0×	49 0.9×	18	491
Mingxi Wang China	16	250 0.8×	88 0.7×	96 1.0×	25 0.4×	59 1.1×	34	537
Samira Jahangiri Iran	7	260 0.8×	87 0.7×	51 0.5×	57 1.0×	129 2.5×	10	436
Liang Bao China	15	254 0.8×	91 0.7×	96 1.0×	52 0.9×	54 1.0×	38	593
Meena Prasad United States	5	520 1.6×	120 1.0×	256 2.6×	98 1.7×	53 1.0×	14	908
Shima Rahmati Iran	13	420 1.3×	64 0.5×	160 1.6×	31 0.5×	37 0.7×	30	708
Qian Zheng China	11	195 0.6×	57 0.5×	61 0.6×	55 0.9×	45 0.9×	19	490
Zuzana Šinkorová Czechia	14	265 0.8×	53 0.4×	71 0.7×	61 1.0×	114 2.2×	60	581
Xiangpeng Wang China	14	449 1.4×	94 0.7×	211 2.1×	107 1.8×	81 1.6×	24	758
Ning Huang China	13	246 0.8×	76 0.6×	35 0.3×	70 1.2×	49 0.9×	36	588

Countries citing papers authored by Cheng‐mei Tian

Since Specialization

Citations

This map shows the geographic impact of Cheng‐mei Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng‐mei Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng‐mei Tian more than expected).

Fields of papers citing papers by Cheng‐mei Tian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng‐mei Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng‐mei Tian. The network helps show where Cheng‐mei Tian may publish in the future.

Co-authorship network of co-authors of Cheng‐mei Tian

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng‐mei Tian. A scholar is included among the top collaborators of Cheng‐mei Tian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng‐mei Tian. Cheng‐mei Tian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tian, Cheng‐mei, Meifeng Yang, Kong Chen, et al.. (2025). Microbiome–Gut–Brain Axis: Implications for the Links Between Inflammatory Bowel Disease and Neuropsychiatric Disorders. Journal of Inflammation Research. Volume 18. 13183–13212. 1 indexed citations

Chen, Kong, Longbin Huang, Meifeng Yang, et al.. (2025). Milk-derived extracellular vesicles: nature’s nanocarriers for drug delivery and therapeutics. Frontiers in Pharmacology. 16. 1595891–1595891. 1 indexed citations

Zhao, Hailan, Mai Zhang, Cheng‐mei Tian, et al.. (2025). Lactobacillus johnsonii-derived extracellular vesicles restore mucosal immunity via taurine-linked Th17/Treg and IgA/IgG regulation in colitis. Journal of Nanobiotechnology. 23(1). 612–612. 1 indexed citations

Chen, Kong, Longbin Huang, Yuan Zhang, et al.. (2025). Engineering the microbiome: A novel frontier in inflammatory bowel disease treatment. Chinese Medical Journal.

Zhang, Yuan, Liyu Chen, Cheng‐mei Tian, et al.. (2025). Exosomal biomarkers: A novel frontier in the diagnosis of gastrointestinal cancers. World Journal of Gastrointestinal Oncology. 17(4). 103591–103591.

Zhu, Min‐zheng, Hailan Zhao, Yuan Zhang, et al.. (2025). “One stone three birds”: Andrographis paniculata-derived exosome-like nanoparticles mitigate dextran sulfate sodium-induced colitis. Chinese Medical Journal. 139(6). 891–905.

Hu, Peng, Cheng‐mei Tian, Kong Chen, et al.. (2024). Dissecting Innate and Adaptive Immunity in Inflammatory Bowel Disease: Immune Compartmentalization, Microbiota Crosstalk, and Emerging Therapies. Journal of Inflammation Research. Volume 17. 9987–10014. 4 indexed citations

Chen, Kong, et al.. (2024). Restore Intestinal Barrier Integrity: An Approach for Inflammatory Bowel Disease Therapy. Journal of Inflammation Research. Volume 17. 5389–5413. 20 indexed citations

Zhu, Min‐zheng, Haoming Xu, Yujie Liang, et al.. (2023). Edible exosome-like nanoparticles from portulaca oleracea L mitigate DSS-induced colitis via facilitating double-positive CD4+CD8+T cells expansion. Journal of Nanobiotechnology. 21(1). 309–309. 102 indexed citations breakdown →

10.

Xu, Haoming, Jing Xu, Min‐zheng Zhu, et al.. (2023). Therapeutic potential of gene therapy for gastrointestinal diseases: Advancements and future perspectives. Molecular Therapy — Oncolytics. 30. 193–215. 4 indexed citations

11.

Tian, Cheng‐mei, Meifeng Yang, Haoming Xu, et al.. (2023). Emerging role of bacterial outer membrane vesicle in gastrointestinal tract. Gut Pathogens. 15(1). 20–20. 37 indexed citations

12.

Tian, Cheng‐mei, Meifeng Yang, Haoming Xu, et al.. (2023). Mesenchymal Stem Cell-derived Exosomes: Novel Therapeutic Approach for Inflammatory Bowel Diseases. Stem Cells International. 2023. 1–16. 24 indexed citations

13.

Li, Defeng, Qi Tang, Meifeng Yang, et al.. (2023). Plant-derived exosomal nanoparticles: potential therapeutic for inflammatory bowel disease. Nanoscale Advances. 5(14). 3575–3588. 29 indexed citations

14.

Tian, Cheng‐mei, Meifeng Yang, Haoming Xu, et al.. (2023). Stem cell-derived intestinal organoids: a novel modality for IBD. Cell Death Discovery. 9(1). 255–255. 32 indexed citations

15.

Zhu, Min‐zheng, Meifeng Yang, Yang Song, et al.. (2023). Exploring the efficacy of herbal medicinal products as oral therapy for inflammatory bowel disease. Biomedicine & Pharmacotherapy. 165. 115266–115266. 14 indexed citations

16.

Tian, Cheng‐mei, Meifeng Yang, Haoming Xu, et al.. (2023). Stem Cell Therapy in Inflammatory Bowel Disease: A Review of Achievements and Challenges. Journal of Inflammation Research. Volume 16. 2089–2119. 33 indexed citations

17.

Xu, Haoming, Jing Xu, Min‐zheng Zhu, et al.. (2023). Application of Nanoparticles in the Diagnosis of Gastrointestinal Diseases: A Complete Future Perspective. International Journal of Nanomedicine. Volume 18. 4143–4170. 18 indexed citations

18.

Li, Defeng, Qisong Liu, Meifeng Yang, et al.. (2023). Nanomaterials for mRNA ‐based therapeutics: Challenges and opportunities. Bioengineering & Translational Medicine. 8(3). e10492–e10492. 48 indexed citations

19.

Li, Defeng, Meifeng Yang, Haoming Xu, et al.. (2022). Nanoparticles for oral delivery: targeted therapy for inflammatory bowel disease. Journal of Materials Chemistry B. 10(31). 5853–5872. 65 indexed citations

20.

Xu, Haoming, Jing Xu, Meifeng Yang, et al.. (2022). Epigenetic DNA methylation of Zbtb7b regulates the population of double-positive CD4+CD8+ T cells in ulcerative colitis. Journal of Translational Medicine. 20(1). 289–289. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact